Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.

Saved in:
Bibliographic Details
Title: Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.
Authors: Beech C; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Wilcock DM; Institute for Experimental Pathology, ARUP Laboratories., Moore KH; Institute for Experimental Pathology, ARUP Laboratories., Rowe L; Institute for Experimental Pathology, ARUP Laboratories., Mahlow J; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Jedrzkiewicz J; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Cleary AS; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Lomo L; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Ruano AL; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Gering M; Institute for Experimental Pathology, ARUP Laboratories., Bradshaw D; Institute for Experimental Pathology, ARUP Laboratories., Maughan M; Institute for Experimental Pathology, ARUP Laboratories., Tran P; Institute for Experimental Pathology, ARUP Laboratories., Davis R; Institute for Experimental Pathology, ARUP Laboratories., Affolter K; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Albertson DJ; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Adelhardt P; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Kim J; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Coleman JF; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Deftereos G; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT.; The Department of Pathology, University of California San Francisco, San Francisco, CA., Gulbahce EH; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT., Sirohi D; Institute for Experimental Pathology, ARUP Laboratories.; The Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT.; The Department of Pathology, University of California San Francisco, San Francisco, CA.
Source: Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2025 Mar 01; Vol. 33 (2), pp. 91-102. Date of Electronic Publication: 2025 Jan 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100888796 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4058 (Electronic) Linking ISSN: 15334058 NLM ISO Abbreviation: Appl Immunohistochem Mol Morphol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4058
DOI:10.1097/PAI.0000000000001247